Steven Coutre
Professor
Medicine - Hematology
Stanford University School of Medicine
United States of America
Biography
Dr. Steven Coutre work emphasizes both patient care and translational research. He focus on both the hematologic malignancies as well as conditions such as anemia and blood clotting disorders. Their program offers novel treatments for many of these conditions in the context of clinical trials. They also have comprehensive laboratory services offering the most up-to-date testing for both the diagnosis and management of complex hematologic problems.
Research Interest
Recent clinical protocols involved the treatment of acute myeloid leukemia, acute lymphoid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, multiple myeloma, prolymphocytic leukemia, hypereosinophilic syndrome, systemic mastocytosis and heparin-induced thrombocytopenia.
Publications
-
Furman RR, Sharman JP, Coutre SE, Cheson BD, Pagel JM, et al. (2014) Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Eng j med 370: 997-1007
-
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, et al. (2014) Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Eng j med 371: 213-223
-
O'Brien SM, Lamanna N, Kipps TJ, Flinn I, Zelenetz AD, et al. (2015) Phase 2 study of idelalisib plus rituximab in treatment-naive older patients with chronic lymphocytic leukemia. Blood 126: 2686-2694
